Brief: Metacrine Reports Business Updates And Third Quarter 2020 Financial Results
Nov 12 (Reuters) - Metacrine, Inc. MTCR.O :
* METACRINE REPORTS BUSINESS UPDATES AND THIRD QUARTER 2020
FINANCIAL RESULTS
* METACRINE, INC. - EXPECTS TO ANNOUNCE TOPLINE RESULTS FROM
ITS
PHASE 1 CLINICAL STUDY IN HEALTHY VOLUNTEERS OF MET642 BEFORE
END OF 2020
* METACRINE, INC. - QTRLY LOSS PER SHARE $1.41
* METACRINE, INC. - QTRLY COMPANY ANTICIPATES BEGINNING MET
409
PHASE 2A COMBINATION TRIAL IN FIRST HALF OF 2021
Source text for Eikon: ID:nGNX901W8r
Further company coverage: MTCR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Metacrine
See all newsMetacrine Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Metacrine - Filed Certificate Of Dissolution With Secretary Of State Of State Of Delaware To Effect Complete Liquidation And Dissolution Of Company
Brief: Metacrine Inc Common Stock Will Be Delisted From Nasdaq
Brief: Metacrine Inc- On Jan 31, Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Brief: Metacrine CEO Preston Klassen Was Terminated From All Positions